RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4

Neurosci Lett 366(2):182-186 · 2004 · PMID 15276243

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

53편 검색→52편 판독→36편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Choline acetyltransferase and apolipoprotein E in Alzheimer disease Choline acetyltransferase and apolipoprotein E in Alzheimer disease

출판 연도

1995: 2편219951996: 2편21997: 5편51998: 2편21999: 2편22000: 4편420002001: 1편12002: 1편12004: 4편420052006: 3편32007: 2편22009: 1편12010: 1편120102011: 1편12012: 2편22016: 3편32016

선별된 36편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01genes · polymorphisms20편

  1. 0.95

    Choline acetyltransferase 2384G>a polymorphism and the risk of Alzheimer disease RECODE

    Lee JJ, Jo SA, Park JH et al. · Alzheimer disease and associated disorders · 2012

  2. 0.95

    Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4 이 논문

    Kim KW, Suh YJ, Park WY et al. · Neuroscience letters · 2004

  3. 0.94

    ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease

    Ahn Jo S, Ahn K, Kim JH et al. · Clinica chimica acta; international journal of clinical chemistry · 2006

  4. 0.94

    E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease

    Corey-Bloom J, Tiraboschi P, Hansen LA et al. · Neurology · 2000

  5. 0.93

    Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice

    Dolejsi E, Liraz O, Rudajev V et al. · Journal of neurochemistry · 2016

  6. 0.91

    Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample

    Piccardi M, Congiu D, Squassina A et al. · American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2007

  7. 0.89

    Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies

    Grunblatt E, Reif A, Jungwirth S et al. · Journal of psychiatric research · 2011

  8. 0.86

    Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice

    Krzywkowski P, Ghribi O, Gagne J et al. · Neuroscience · 1999

  9. 0.83

    Real-time multiplex PCR assay for genotyping of three apolipoprotein E alleles and two choline acetyltransferase alleles with three hybridization probes RECODE

    Park HD, Park KU, Kim KW et al. · Clinical chemistry and laboratory medicine · 2007

  10. 0.82

    Alzheimer disease without neocortical neurofibrillary tangles: "a second look"

    Tiraboschi P, Sabbagh MN, Hansen LA et al. · Neurology · 2004

  11. 0.80

    Butyrylcholinesterase K and Apolipoprotein E-varepsilon4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects

    De Beaumont L, Pelleieux S, Lamarre-Theroux L et al. · Journal of Alzheimer's disease : JAD · 2016

  12. 0.80

    Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease

    Reid RT, Sabbagh MN, Thal LJ · Journal of neural transmission (Vienna, Austria : 1996) · 2001

  13. 0.77

    The cholinergic neuronal phenotype in Alzheimer's disease

    Blusztajn JK, Berse B · Metabolic brain disease · 2000

  14. 0.72

    Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease

    Gilmor ML, Erickson JD, Varoqui H et al. · The Journal of comparative neurology · 1999

  15. 0.69

    Amyloid-beta peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAbetaACs

    Kumar R, Nordberg A, Darreh-Shori T · Brain : a journal of neurology · 2016

  16. 0.68

    Cholinergic dysfunction in diseases with Lewy bodies

    Tiraboschi P, Hansen LA, Alford M et al. · Neurology · 2000

  17. 0.67

    Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease

    Gozes I, Bachar M, Bardea A et al. · Journal of neurobiology · 1997

  18. 0.62

    Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study

    Grunblatt E, Zehetmayer S, Bartl J et al. · Journal of psychiatric research · 2009

  19. 0.53

    ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus

    Dubelaar EJG, Verwer RWH, Hofman MA et al. · Journal of neuropathology and experimental neurology · 2004

  20. 0.53

    Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease

    Counts SE, Chen EY, Che S et al. · Dementia and geriatric cognitive disorders · 2006

02brain · temporal16편

  1. 0.96

    A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele

    Soininen H, Kosunen O, Helisalmi S et al. · Neuroscience letters · 1995

  2. 0.95

    Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes

    Svensson AL, Warpman U, Hellstrom-Lindahl E et al. · Neuroscience letters · 1997

  3. 0.94

    Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease

    Lai MKP, Tsang SWY, Garcia-Alloza M et al. · Neurobiology of disease · 2006

  4. 0.94

    Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

    Poirier J, Delisle MC, Quirion R et al. · Proceedings of the National Academy of Sciences of the United States of America · 1995

  5. 0.93

    Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease

    Tiraboschi P, Hansen LA, Masliah E et al. · Neurology · 2004

  6. 0.91

    Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation

    Buttini M, Yu GQ, Shockley K et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002

  7. 0.89

    Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype

    Allen SJ, MacGowan SH, Tyler S et al. · Neuroscience letters · 1997

  8. 0.89

    Altered NCAM expression associated with the cholinergic system in Alzheimer's disease

    Aisa B, Gil-Bea FJ, Solas M et al. · Journal of Alzheimer's disease : JAD · 2010

  9. 0.88

    Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury

    Fagan AM, Murphy BA, Patel SN et al. · Experimental neurology · 1998

  10. 0.88

    Absence of central cholinergic deficits in ApoE knockout mice

    Anderson R, Higgins GA · Psychopharmacology · 1997

  11. 0.86

    Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease

    Beffert U, Poirier J · Annals of the New York Academy of Sciences · 1996

  12. 0.83

    No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice

    Bronfman FC, Tesseur I, Hofker MH et al. · Neuroscience · 2000

  13. 0.82

    M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice

    Fisher A, Brandeis R, Chapman S et al. · Journal of neurochemistry · 1998

  14. 0.78

    Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias

    Morris CM, Massey HM, Benjamin R et al. · Journal of neural transmission. Supplementum · 1996

  15. 0.60

    Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele

    Arendt T, Schindler C, Bruckner MK et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 1997

  16. 0.53

    Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity

    Bao F, Wicklund L, Lacor PN et al. · Neurobiology of aging · 2012